UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors

Advances in therapy, 2020-08, Vol.37 (8), p.3606-3618

2020

Volltextzugriff (PDF)

Caveolin‐1 is a novel regulator of K‐RAS‐dependent migration in colon carcinogenesis

International journal of cancer, 2013-07, Vol.133 (1), p.43-57

2013

Volltextzugriff (PDF)

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

Nature communications, 2015-04, Vol.6 (1), p.6411-6411, Article 6411

2015

Volltextzugriff (PDF)

Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis

Molecular carcinogenesis, 2008-07, Vol.47 (7), p.538-553

2008

Volltextzugriff (PDF)

In Response: Letter Received From Dr. Tadashi Nishimura Titled “What About Palliative and Supportive Care Landscapes?”

Journal of thoracic oncology, 2022-12, Vol.17 (12), p.e95-e96

2022

Volltextzugriff (PDF)

Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer

Therapeutic innovation & regulatory science, 2020-09, Vol.54 (5), p.1208-1214

2020

Volltextzugriff (PDF)

Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct

Blood, 2014-05, Vol.123 (20), p.e110-e122

2014

Volltextzugriff (PDF)

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Clinical cancer research, 2021-05, Vol.27 (9), p.2424-2429

2021

Volltextzugriff (PDF)

Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer

JTO clinical and research reports, 2022-02, Vol.3 (2), p.100269, Article 100269

2022

Volltextzugriff (PDF)

Myeloid Zinc Finger 1 and GA Binding Protein Co‐Operate with Sox2 in Regulating the Expression of Yes‐Associated Protein 1 in Cancer Cells

Stem cells (Dayton, Ohio), 2017-12, Vol.35 (12), p.2340-2350

2017

Volltextzugriff (PDF)

A qualitative study of interactions with oncologists among patients with advanced lung cancer

Supportive care in cancer, 2022-11, Vol.30 (11), p.9049-9055

2022

Volltextzugriff (PDF)

SOX2 Regulates YAP1 to Maintain Stemness and Determine Cell Fate in the Osteo-Adipo Lineage

Cell reports (Cambridge), 2013-06, Vol.3 (6), p.2075-2087

2013

Volltextzugriff (PDF)

Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation

Archives of pathology & laboratory medicine (1976), 2024-07, Vol.148 (7), p.757-774

2024

Volltextzugriff (PDF)

Grounding evaluation design in the socio-ecological model of health: a logic framework for the assessment of a national routine immunization communication initiative in Kyrgyzstan

Global health promotion, 2020-12, Vol.27 (4), p.59-68

2020

Volltextzugriff (PDF)

Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage

Molecular and Cellular Biology, 2011-11, Vol.31 (22), p.4593-4608

2011

Volltextzugriff (PDF)

Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ

Molecular cell, 2016-01, Vol.61 (1), p.98-110

2016

Volltextzugriff (PDF)

Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1815-1817

2018

Volltextzugriff (PDF)

Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole

PloS one, 2017-02, Vol.12 (2), p.e0171256-e0171256

2017

Volltextzugriff (PDF)

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.338-342

2019

Volltextzugriff (PDF)

A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria

JAMA oncology, 2022-09, Vol.8 (9), p.1333

2022

Volltextzugriff (PDF)

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Cancer medicine (Malden, MA), 2022-01, Vol.11 (2), p.530-538

2022

Volltextzugriff (PDF)

Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis

Nutrition and cancer, 2006-01, Vol.56 (2), p.172-181

2006

Volltextzugriff (PDF)

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

Journal of thoracic oncology, 2018-06, Vol.13 (6), p.748-751

2018

Volltextzugriff (PDF)

Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group

Clinical lung cancer, 2020-07, Vol.21 (4), p.295-307

2020

Volltextzugriff (PDF)

The Effect of Fluid Flow Shear Stress and Substrate Stiffness on Yes-Associated Protein (YAP) Activity and Osteogenesis in Murine Osteosarcoma Cells

Cancers, 2021-06, Vol.13 (13), p.3128

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(78)
Dissertationen
(1)

Sprache

Englisch
(79)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors

Caveolin‐1 is a novel regulator of K‐RAS‐dependent migration in colon carcinogenesis

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis

In Response: Letter Received From Dr. Tadashi Nishimura Titled “What About Palliative and Supportive Care Landscapes?”

Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer

Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer

Myeloid Zinc Finger 1 and GA Binding Protein Co‐Operate with Sox2 in Regulating the Expression of Yes‐Associated Protein 1 in Cancer Cells

A qualitative study of interactions with oncologists among patients with advanced lung cancer

SOX2 Regulates YAP1 to Maintain Stemness and Determine Cell Fate in the Osteo-Adipo Lineage

Grounding evaluation design in the socio-ecological model of health: a logic framework for the assessment of a national routine immunization communication initiative in Kyrgyzstan

Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage

Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ

Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials

Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable

A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group

The Effect of Fluid Flow Shear Stress and Substrate Stiffness on Yes-Associated Protein (YAP) Activity and Osteogenesis in Murine Osteosarcoma Cells

Suchergebnisse filtern